cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.4pdz7w
title: Occurrence Download

description: A dataset containing 2298 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Bursera excelsa (Kunth) Engl."
 ]
}

 The dataset includes 2298 records from 90 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012803-241007104925546/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25345/c5br8mt5v
title: MassIVE MSV000096071 - Fisher et al CoREST Inhibition
title: Immunopeptidome analysis in support of the manuscript "CoREST Inhibition Alters RNA Splicing to Promote Neoantigen Expression and Enhance Tumor Immunity"
DOI: 10.5281/zenodo.13921967
title: Learning Broken Symmetries with Resimulation and Encouraged Invariance

description: This dataset corresponds to "Learning Broken Symmetries with Resimulation and Encouraged Invariance" (2311.05952) and is meant for use with the code at https://github.com/Edwit4/learning_broken_symmetries.
DOI: 10.5281/zenodo.13921968
title: Learning Broken Symmetries with Resimulation and Encouraged Invariance

description: This dataset corresponds to "Learning Broken Symmetries with Resimulation and Encouraged Invariance" (2311.05952) and is meant for use with the code at https://github.com/Edwit4/learning_broken_symmetries.
DOI: 10.15468/dl.rjr8jd
title: Occurrence Download

description: A dataset containing 2078672 species occurrences available in GBIF matching the query:
{
 "and" : [
 "BasisOfRecord is Specimen",
 "MediaType is Image",
 "OccurrenceStatus is Present",
 "TaxonKey is Lepidoptera"
 ]
}

 The dataset includes 2078672 records from 169 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012786-241007104925546/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.zas8v3
title: Occurrence Download

description: A dataset containing 783 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Bursera heteresthes Bullock"
 ]
}

 The dataset includes 783 records from 64 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012804-241007104925546/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.7dn5g8
title: Occurrence Download

description: A dataset containing 1 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Ischnocnema sanderi Padial, Reichle & De la Riva, 2005"
 ]
}

 The dataset includes 1 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012806-241007104925546/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.249smn
title: Occurrence Download

description: A dataset containing 32709 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Rhizophora mangle L."
 ]
}

 The dataset includes 32709 records from 385 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012808-241007104925546/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.388m5p
title: Occurrence Download

description: A dataset containing 1903 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Bursera schlechtendalii Engl."
 ]
}

 The dataset includes 1903 records from 84 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012809-241007104925546/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.q2n6hr
title: Occurrence Download

description: A dataset containing 1192 species occurrences available in GBIF matching the query:
{
 "and" : [
 "BasisOfRecord is Human Observation",
 "CoordinateUncertaintyInMeters 0.0-9959.0",
 "Geometry POLYGON((-125.73673 25.07058,-63.3116 25.07058,-63.3116 49.08716,-125.73673 49.08716,-125.73673 25.07058))",
 "TaxonKey is Scantius aegyptius (Linnaeus, 1758)"
 ]
}

 The dataset includes 1192 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012810-241007104925546/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.26179/vd19-5858
title: Geotechnical Investigations Davis Aerodrome Project - Water Bodies Report - 31 May 2022
DOI: 10.15468/dl.bc3we4
title: Occurrence Download

description: A dataset containing 293 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Bursera cinerea Engl."
 ]
}

 The dataset includes 293 records from 33 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012811-241007104925546/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.5henq2
title: Occurrence Download

description: A dataset containing 932 species occurrences available in GBIF matching the query:
{
 "and" : [
 "BasisOfRecord is Human Observation",
 "CoordinateUncertaintyInMeters 0.0-10000.0",
 "Geometry POLYGON((-100.18184 33.74875,-103.91768 31.90281,-98.86331 25.80827,-96.68041 25.88152,-95.55233 28.91414,-96.19695 31.36075,-100.18184 33.74875))",
 "TaxonKey is Molothrus aeneus (Wagler, 1829)"
 ]
}

 The dataset includes 932 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012812-241007104925546/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.qv5by8
title: Occurrence Download

description: A dataset containing 104938 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Lepidium draba L."
 ]
}

 The dataset includes 104938 records from 1227 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012805-241007104925546/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.13145/bacdive109634.20230509.8.1
title: Streptomyces sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive109635.20230509.8.1
title: Streptomyces sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive109636.20230509.8.1
title: Streptomyces sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive109637.20230509.8.1
title: Streptomyces sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive109638.20230509.8.1
title: Streptomyces sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.5281/zenodo.14609655
title: AlphaFold3 ensembles of 100 randomly selected human proteins with 100 conformers per ensemble

description: 100 proteins were selected from the set of human proteins covered by the AlphaFold Protein Structure Database. For each protein, 20 random seed values in the range form 1 to 999999999 were generated. Based on the canonical peptide sequence of the protein, json input files for the AlphaFold3 server were created and then manually submitted. The output was manually downloaded and processed with Matlab scripts that are contained in the folders for the individual proteins. This processing requires MMMx, which is available at https://github.com/gjeschke/MMMx. The main folder contains two additional Matlab scripts for analysis of the whole set of ensembles.
DOI: 10.5281/zenodo.14609656
title: AlphaFold3 ensembles of 100 randomly selected human proteins with 100 conformers per ensemble

description: 100 proteins were selected from the set of human proteins covered by the AlphaFold Protein Structure Database. For each protein, 20 random seed values in the range form 1 to 999999999 were generated. Based on the canonical peptide sequence of the protein, json input files for the AlphaFold3 server were created and then manually submitted. The output was manually downloaded and processed with Matlab scripts that are contained in the folders for the individual proteins. This processing requires MMMx, which is available at https://github.com/gjeschke/MMMx. The main folder contains two additional Matlab scripts for analysis of the whole set of ensembles.
DOI: 10.13145/bacdive109639.20230509.8.1
title: Streptomyces sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive109640.20230509.8.1
title: Streptomyces sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive109641.20230509.8.1
title: Streptomyces sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.6084/m9.figshare.27968633
title: Profile Monitoring via Eigenvector Perturbation

description: In Statistical Process Control, control charts are often used to detect undesirable behavior of sequentially observed quality characteristics. Designing a control chart with desirably low False Alarm Rate (FAR) and detection delay (<i>ARL</i><sub>1</sub>) is an important challenge especially when the sampling rate is high and the control chart has an In-Control Average Run Length, called <i>ARL</i><sub>0</sub>, of 200 or more, as commonly found in practice. Unfortunately, arbitrary reduction of the FAR typically increases the <i>ARL</i><sub>1</sub>. Motivated by eigenvector perturbation theory, we propose the Eigenvector Perturbation Control Chart for computationally fast nonparametric profile monitoring. Our simulation studies show that it outperforms the competition and achieves both ARL1≈1 and ARL0&gt;106.
DOI: 10.6084/m9.figshare.27968633.v1
title: Profile Monitoring via Eigenvector Perturbation

description: In Statistical Process Control, control charts are often used to detect undesirable behavior of sequentially observed quality characteristics. Designing a control chart with desirably low False Alarm Rate (FAR) and detection delay (<i>ARL</i><sub>1</sub>) is an important challenge especially when the sampling rate is high and the control chart has an In-Control Average Run Length, called <i>ARL</i><sub>0</sub>, of 200 or more, as commonly found in practice. Unfortunately, arbitrary reduction of the FAR typically increases the <i>ARL</i><sub>1</sub>. Motivated by eigenvector perturbation theory, we propose the Eigenvector Perturbation Control Chart for computationally fast nonparametric profile monitoring. Our simulation studies show that it outperforms the competition and achieves both ARL1≈1 and ARL0&gt;106.
DOI: 10.6084/m9.figshare.27188472
title: Efficacy and safety of tegoprazan for duodenal ulcers in Chinese patients: a multicenter, randomized, double-blind, non-inferiority, phase III study

description: Tegoprazan represents a newly developed potassium-competitive acid blocker utilized for the treatment of acid-related disorders. The present study aimed to explore the therapeutic effectiveness of tegoprazan in Chinese individuals with duodenal ulcers (DU). In the current multicenter, randomized, double-blind, double-dummy, parallel-group, non-inferiority, phase III clinical trial, individuals with DU underwent randomization 1:1 to be administered tegoprazan 50 mg or lansoprazole 30 mg once daily. The primary efficacy endpoint was the 6-week cumulative endoscopic ulcer healing rate. Secondary endpoints included 4-week endoscopic ulcer healing rate and relief of DU-related gastrointestinal symptoms at weeks 2, 4, and 6. Safety analysis encompassed adverse events (AEs) and laboratory indexes. The 6-week cumulative endoscopic ulcer healing rates were 96.9% (188/194) and 99.0% (189/191) in the tegoprazan and lansoprazole groups, respectively, indicating a difference of −2.0% (95% confidence interval (CI) = −4.9 to 0.8) in the full analysis set (FAS). The corresponding healing rates were 98.4% (185/188) and 99.5% (183/184) in the per-protocol set, respectively, indicating a difference of −1.1% (95% CI = −3.1 to 1.0). The 4-week healing rates in the tegoprazan and lansoprazole groups were 89.2% (173/194) and 88.5% (169/191) in the FAS, respectively, with a difference of 0.7% (95% CI = −5.6 to 7.0). Treatment-related AEs, all mild-to-moderate, were reported in 38.2% (78/204) and 48.2% (94/195) of participants in the tegoprazan and lansoprazole groups, respectively. Tegoprazan 50 mg once daily is effective and non-inferior to lansoprazole 30 mg once daily in Chinese patients with DU, showing a promising safety and tolerability profile. NCT05010954.
DOI: 10.6084/m9.figshare.27266666
title: Impact of socioeconomic determinants on outcomes of eight select conditions for which self-care is a modality for prevention and treatment: a scoping review

description: We conducted a scoping review of peer-reviewed literature published between January 1, 1990 and October 31, 2021, to identify socioeconomic determinants that contribute to higher burden and adverse outcomes in diseases for which self-care is an important modality of treatment and prevention. We identified these diseases using over-the-counter medicines sales data sourced from IQVIA. We searched Ovid Medline, PubMed, and EMBASE databases for articles published in English using inclusion/exclusion criteria. We analyzed articles covering 42 diseases that qualified as cardiovascular disorders (219 studies including ischemic heart disease, myocardial infarction, stroke, and related risk factors such as hypertension, dyslipidemia and atrial fibrillation), nutritional disorders (66 studies including malnutrition which encompasses undernutrition and micronutrient deficiencies, and anemia), digestive disorders (40 studies including gastroesophageal reflux disorder, inflammatory bowel disease, and dyspepsia), allergy disorders (40 studies including asthma and allergic rhinitis), pain disorders (14 studies including lower back pain, knee pain, generalized musculoskeletal pain and headaches), dermatological disorders (23 studies including atopic dermatitis [eczema], occupational dermatosis, and facial dermatitis), respiratory disorders (11 studies including chronic cough, pneumonia, chronic bronchitis, wheezing, and influenza), and gynecological disorders (29 studies including bacterial vaginosis and trichomoniasis vaginosis). We found that lifestyle factors were the commonly reported risk factors, and residential segregation, education, and income were the commonly reported socioeconomic determinants. A closer analysis of income within each disorder revealed that it is more often associated with health conditions that are self-limiting. Although we did not find any discernible relationship between the commonly reported socioeconomic factors and the prevalence of self-medication for the health conditions considered, income plays an important role in the burden and outcomes of conditions that require more self-care compared to those that require less self-care.
DOI: 10.6084/m9.figshare.27266666.v2
title: Impact of socioeconomic determinants on outcomes of eight select conditions for which self-care is a modality for prevention and treatment: a scoping review

description: We conducted a scoping review of peer-reviewed literature published between January 1, 1990 and October 31, 2021, to identify socioeconomic determinants that contribute to higher burden and adverse outcomes in diseases for which self-care is an important modality of treatment and prevention. We identified these diseases using over-the-counter medicines sales data sourced from IQVIA. We searched Ovid Medline, PubMed, and EMBASE databases for articles published in English using inclusion/exclusion criteria. We analyzed articles covering 42 diseases that qualified as cardiovascular disorders (219 studies including ischemic heart disease, myocardial infarction, stroke, and related risk factors such as hypertension, dyslipidemia and atrial fibrillation), nutritional disorders (66 studies including malnutrition which encompasses undernutrition and micronutrient deficiencies, and anemia), digestive disorders (40 studies including gastroesophageal reflux disorder, inflammatory bowel disease, and dyspepsia), allergy disorders (40 studies including asthma and allergic rhinitis), pain disorders (14 studies including lower back pain, knee pain, generalized musculoskeletal pain and headaches), dermatological disorders (23 studies including atopic dermatitis [eczema], occupational dermatosis, and facial dermatitis), respiratory disorders (11 studies including chronic cough, pneumonia, chronic bronchitis, wheezing, and influenza), and gynecological disorders (29 studies including bacterial vaginosis and trichomoniasis vaginosis). We found that lifestyle factors were the commonly reported risk factors, and residential segregation, education, and income were the commonly reported socioeconomic determinants. A closer analysis of income within each disorder revealed that it is more often associated with health conditions that are self-limiting. Although we did not find any discernible relationship between the commonly reported socioeconomic factors and the prevalence of self-medication for the health conditions considered, income plays an important role in the burden and outcomes of conditions that require more self-care compared to those that require less self-care.
DOI: 10.13145/bacdive109642.20230509.8.1
title: Streptomyces sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.6084/m9.figshare.27188472.v2
title: Efficacy and safety of tegoprazan for duodenal ulcers in Chinese patients: a multicenter, randomized, double-blind, non-inferiority, phase III study

description: Tegoprazan represents a newly developed potassium-competitive acid blocker utilized for the treatment of acid-related disorders. The present study aimed to explore the therapeutic effectiveness of tegoprazan in Chinese individuals with duodenal ulcers (DU). In the current multicenter, randomized, double-blind, double-dummy, parallel-group, non-inferiority, phase III clinical trial, individuals with DU underwent randomization 1:1 to be administered tegoprazan 50 mg or lansoprazole 30 mg once daily. The primary efficacy endpoint was the 6-week cumulative endoscopic ulcer healing rate. Secondary endpoints included 4-week endoscopic ulcer healing rate and relief of DU-related gastrointestinal symptoms at weeks 2, 4, and 6. Safety analysis encompassed adverse events (AEs) and laboratory indexes. The 6-week cumulative endoscopic ulcer healing rates were 96.9% (188/194) and 99.0% (189/191) in the tegoprazan and lansoprazole groups, respectively, indicating a difference of −2.0% (95% confidence interval (CI) = −4.9 to 0.8) in the full analysis set (FAS). The corresponding healing rates were 98.4% (185/188) and 99.5% (183/184) in the per-protocol set, respectively, indicating a difference of −1.1% (95% CI = −3.1 to 1.0). The 4-week healing rates in the tegoprazan and lansoprazole groups were 89.2% (173/194) and 88.5% (169/191) in the FAS, respectively, with a difference of 0.7% (95% CI = −5.6 to 7.0). Treatment-related AEs, all mild-to-moderate, were reported in 38.2% (78/204) and 48.2% (94/195) of participants in the tegoprazan and lansoprazole groups, respectively. Tegoprazan 50 mg once daily is effective and non-inferior to lansoprazole 30 mg once daily in Chinese patients with DU, showing a promising safety and tolerability profile. NCT05010954.
DOI: 10.13145/bacdive109643.20230509.8.1
title: Streptomyces sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.6084/m9.figshare.27152678.v1
title: Getting Help During Active Pain Crises in Sickle Cell Disease: Patient and Caregiver Perspectives in Canada

description: <b>What is this summary about?</b> This is a plain language summary of an article originally published in <i>Patient Preference and Adherence</i>. This study aimed to identify the notable symptoms and impacts of sickle cell disease from the point of view of individuals living with sickle cell disease and their caregivers. The study also sought to understand the factors involved in individuals living with sickle cell disease’ and caregivers’ decisions and preferences if and when they seek care during a pain crisis. This summary describes: the <b>symptoms experienced</b> by adolescents and adults living with sickle cell disease and their severity; the <b>treatments</b> they and their caregivers prefer to use when they are experiencing a pain crisis; and the <b>factors</b> that go into deciding when and whether individuals living with sickle cell disease and their caregivers should seek outside help -- to go to a hospital, for example - during a pain crisis. <b>What were the results?</b> Individuals living with sickle cell disease undergoing an acute pain crisis and their caregivers consider many factors when deciding whether to seek care at a medical facility. These include:
The intensity of their symptomsIf the facility has a treatment plan for them already in placeIf the facility has long wait timesIf the facility has an understanding and compassionate staffThe individual's age and ability to manage their daily responsibilities
 The intensity of their symptoms If the facility has a treatment plan for them already in place If the facility has long wait times If the facility has an understanding and compassionate staff The individual's age and ability to manage their daily responsibilities Racial bias, shown in the actions and lack of empathy of Emergency Department staff toward individuals living with sickle cell disease, frequently factored into the individuals' and caregivers’ decision-making and hinders their ability to get the treatment needed during a pain crisis. <b>What do the results mean?</b> There is a need for a unified care team at medical facilities that treats all individuals living with sickle cell disease with the same high level of empathy and treatment quality and for a strong support system for individuals living with sickle cell disease outside of the hospital or clinic. <b>This is an abstract of the Plain Language Summary of Publication article.</b> View the full Plain Language Summary PDF of this article to read the full-text Link to original article here